{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T07:53:04Z","timestamp":1774684384647,"version":"3.50.1"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[1996,2,1]],"date-time":"1996-02-01T00:00:00Z","timestamp":823132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1996,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In this study, we investigated the importance of the beta 2-integrins for the development of tracheal hyperreactivity in a murine model for nonallergic asthma. The response was induced by skin sensitization with dinitrofluorobenzene (DNFB) followed by an intranasal challenge with the same hapten. Twenty-four hours after the challenge, tracheal hyperreactivity, a decrease in T cells in the blood, and increased neutrophil numbers in bronchoalveolar lavage fluid (BALF) and blood were observed. Monoclonal antibodies (mAbs) directed against the alpha-chains of LFA-1 (FD441.8) and Mac-1 (M1\/70) were injected intravenously 2 h before and 2 h after the challenge. Treatment with anti-LFA-1 mAb totally inhibited the development of tracheal hyperreactivity measured 24 h after the challenge, whereas anti-Mac-1 mAb had only a partial effect on this response. The decrease in T cells in the blood, which was also evident 24 h after the challenge, was totally inhibited by treatment with anti-LFA-1, whereas anti-Mac-1 had little effect. The increase in the number of neutrophils in BALF at this time point was completely inhibited by both anti-LFA-1 and anti-Mac-1. In summary, evidence presented in this report highlights the possible importance of the adhesion molecule LFA-1 in the development of tracheal hyperreactivity. Our results suggest that LFA-1 present on T cells may play an integral role in this response.<\/jats:p>","DOI":"10.1164\/ajrccm.153.2.8564091","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T17:53:58Z","timestamp":1365098038000},"page":"521-529","source":"Crossref","is-referenced-by-count":21,"title":["LFA-1, and Not Mac-1, Is Crucial for the Development of Hyperreactivity in a Murine Model of Nonallergic Asthma"],"prefix":"10.1093","volume":"153","author":[{"given":"P G","family":"Bloemen","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T L","family":"Buckley","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M C","family":"van den Tweel","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P A","family":"Henricks","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F A","family":"Redegeld","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A S","family":"Koster","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F P","family":"Nijkamp","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1996,2,1]]},"container-title":["American journal of respiratory and critical care medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/153\/2\/521\/67616682\/ajrccm_153_2_521.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/153\/2\/521\/67616682\/ajrccm_153_2_521.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T07:14:49Z","timestamp":1774682089000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/153\/2\/521\/8552747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,2,1]]},"references-count":0,"journal-issue":{"issue":"2","published-online":{"date-parts":[[1996,2,1]]},"published-print":{"date-parts":[[1996,2,1]]}},"URL":"https:\/\/doi.org\/10.1164\/ajrccm.153.2.8564091","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1996,2]]},"published":{"date-parts":[[1996,2,1]]}}}